Clinical Trials List
2025-01-01 - 2026-12-31
Phase I/II
Recruiting3
ICD-10C14.8
Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9149.8
Malignant neoplasm of other sites within the lip, oral cavity, and pharynx
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Cheng-Lung Hsu 無
- 湯文誠 無
- Hung-Ming Wang 無
- Chi-Ting Liau 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊明翰 Division of Hematology & Oncology
- RUEY-LONG HONG Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
60 participants
